HealthLeaders Media March 25, 2024
Reuters

Elahere was approved for adult patients with a type of cancer which affects the ovaries, fallopian tube, or...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
11 drugs now in shortage
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
FDA Launches ‘Home as a Health Care Hub’ Initiative With Equity Focus

Share This Article